These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9700480)

  • 21. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
    Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
    Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of apolipoprotein E isoform difference on postprandial lipoprotein in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol.
    Superko HR; Haskell WL
    Artery; 1991; 18(6):315-25. PubMed ID: 1750804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause.
    Tolosa M; Peiró S; Real JT; Cano A; Ascaso JF; Carmena R
    Maturitas; 2001 Nov; 40(2):173-81. PubMed ID: 11716996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?
    Gaibar M; Fernández G; Romero-Lorca A; Novillo A; Tejerina A; Bandrés F; Fernández-Santander A
    Int J Biol Markers; 2013 Dec; 28(4):e371-6. PubMed ID: 23828408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation.
    Balakrishnan S; Colling C; Burkman T; Erickson J; Lyden E; Maheshwari H; Mack-Shipman L; Lane J; Larsen J
    Transplantation; 2002 Oct; 74(7):974-7. PubMed ID: 12394840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
    Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
    Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.
    St-Amand J; Moorjanit S; Lupien PJ; Prud'homme D; Després JP
    Metabolism; 1996 Feb; 45(2):261-7. PubMed ID: 8596500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus.
    Milionis HJ; Liberopoulos EN; Elisaf MS
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):160-3. PubMed ID: 11353883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential changes in serum triglyceride levels during adjuvant tamoxifen therapy in breast cancer patients and the effect of dose reduction.
    Liu CL; Yang TL
    Breast Cancer Res Treat; 2003 May; 79(1):11-6. PubMed ID: 12779077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Elkasabany A; Berenson GS
    Metabolism; 2001 Jun; 50(6):696-702. PubMed ID: 11398147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
    Saarto T; Blomqvist C; Ehnholm C; Taskinen MR; Elomaa I
    J Clin Oncol; 1996 Feb; 14(2):429-33. PubMed ID: 8636753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of apolipoprotein E polymorphism on bezafibrate treatment response in dyslipidemic patients.
    Yamada M
    J Atheroscler Thromb; 1997; 4(1):40-4. PubMed ID: 9583353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apo E phenotype and changes in serum lipids in adult patients during growth hormone replacement.
    Leese GP; Wallymahmed M; Wieringa G; VanHeyningen C; MacFarlane IA
    Eur J Endocrinol; 1999 Feb; 140(2):174-9. PubMed ID: 10069664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent effects of Apo E phenotype and plasma triglyceride on lipoprotein particle sizes in the fasting and postprandial states.
    Dart AM; Cooper B
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2465-73. PubMed ID: 10521377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E4 allele influences the response of plasma triglyceride levels to tamoxifen in breast cancer patients.
    Chang NW; Chen FN; Wu CT; Lin CF; Chen DR
    Clin Chim Acta; 2009 Mar; 401(1-2):144-7. PubMed ID: 19103187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertriglyceridemia and lower LDL cholesterol concentration in relation to apolipoprotein E phenotypes in myotonic dystrophy.
    Moorjani S; Gaudet D; Laberge C; Thibault MC; Mathieu J; Morissette J; Lupien PJ; Brun D; Gagné C
    Can J Neurol Sci; 1989 Feb; 16(1):129-33. PubMed ID: 2924207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.